Walleye Capital
ARVN icon

Walleye Capital’s Arvinas ARVN Stock Holding History

Walleye Capital’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Buy
+16,319
New +$152K ﹤0.01% 3717
2026
Q1 		– Sell
-1,617
Closed -$19.2K – 4361
2025
Q4 		$19.2K Sell
1,617
-10,610
-87% -$116K ﹤0.01% 4253
2025
Q3 		$104K Buy
12,227
+7,466
+157% +$56.6K ﹤0.01% 3699
2025
Q2 		$35K Sell
4,761
-119,641
-96% -$881K ﹤0.01% 4130
2025
Q1 		$873K Buy
+124,402
New +$1.95M ﹤0.01% 2083
2024
Q4 		– Sell
-27,245
Closed -$671K – 4819
2024
Q3 		$671K Buy
27,245
+2,088
+8% +$54.5K ﹤0.01% 3030
2024
Q2 		$670K Sell
25,157
-9,431
-27% -$300K ﹤0.01% 3240
2024
Q1 		$1.43M Buy
34,588
+23,573
+214% +$1.03M ﹤0.01% 2247
2023
Q4 		$453K Buy
+11,015
New +$257K ﹤0.01% 3022
2023
Q2 		– Sell
-16,427
Closed -$449K – 4291
2023
Q1 		$449K Buy
+16,427
New +$519K 0.01% 1807
2022
Q3 		– Sell
-61,919
Closed -$2.61M – 3208
2022
Q2 		$2.61M Buy
+61,919
New +$3.11M 0.07% 293
2022
Q1 		– Sell
-15,846
Closed -$1.3M – 2274
2021
Q4 		$1.3M Buy
+15,846
New +$1.29M 0.04% 456

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's ARVN Position: Q2 2026 in Review

Walleye Capital opened a new position in Arvinas (ARVN) in Q2 2026: 16,319 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #3717 among its holdings. This is a return to the name: Walleye Capital previously reported a position in ARVN as recently as Q4 2025.

Walleye Capital first reported a position in ARVN in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.61M in Q2 2022. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Walleye Capital held 16,319 shares of Arvinas worth $136K as of Q2 2026.
  • Arvinas was a new Walleye Capital position in Q2 2026.
  • Arvinas made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3717 holding.
  • Walleye Capital first reported a position in Arvinas in Q4 2021 and has held it in 12 quarters since.
  • Walleye Capital's Arvinas position peaked at $2.61M in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.